Bacteremia is a life-threatening complication in cancer patients.
However, there are limited studies evaluating bacteremia in this patient population.
The objective of this study was to evaluate the microbiological profile as well as the prevalence and predictors of multidrug-resistant organisms (MDROs) among cancer patients admitted with bacteremia.
